PURPOSE: To assess cataract progression after intravitreal triamcinolone injection.
DESIGN: Retrospective, interventional, case-control study. METHODS: Forty-two phakic …

Objective To determine the safety of a single intravitreal injection of triamcinoloneacetonide
(4 mg) in patients with subfoveal choroidal neovascularization causedby age-related …

Background: Intravitreal injection of triamcinolone acetonide appears to be a promising
treatment for a variety of proliferative, edematous, neovascular and inflammatory ocular …

Purpose To investigate the progression of cataract after a high dose (25 mg) intravitreal
triamcinolone acetonide injection in patients with macular oedema secondary to diabetes …

BACKGROUND: To evaluate the intraocular concentration of triamcinolone acetonide after
intravitreal injection. METHODS: The prospective clinical interventional case series study …

OBJECTIVE: To investigate the association between elevated intraocular pressure (IOP) and
accelerated cataract formation in patients treated with intravitreal triamcinolone. DESIGN …

Methods Prospective, non-randomised, interventional cohort case series. A total of 27 eyes
of 27 patients with diabetic macular oedema received an intravitreal injection of 4 mg (0.1 …

Purpose: To describe the short-term complications associated with intravitreal triamcinolone
acetonide (IVTA) injection in the treatment of posterior segment disorders. Methods: The …

Purpose To evaluate whether the addition of cataract surgery to an intravitreal injection of
triamcinolone acetonide markedly increases frequency and spectrum of complications …

Purpose To report the clinical outcome of patients undergoing cataract surgery after one or
repeated intravitreal injections of triamcinolone acetonide as treatment of intraocular …